Emerging Market Outsourcing Report, Q2 2026
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
This expert outsourcing report is a comprehensive look at the pharmaceutical manufacturing landscape for emerging markets in Q2 2026, including analysis of news and trends affecting contract manufacturing organizations (CMOs) and the identification of recent contract service agreements, mergers, acquisitions, and financing among CMOs. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the pharmaceutical value chain that will provide insights into API (biologics and chemical) as well as dose manufacturing and packaging (clinical and commercial) for countries in emerging markets.
Scope
This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from GlobalData's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for –
– CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
– Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
– Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy
Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
Learn about the past quarter’s M&A and financing deals in the manufacturing space.
Identify the latest contract service agreements.
Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
Stay ahead of disruption with updates on supply chain obstacles and new regulations.
Ajanta Pharma Ltd
Alchymars ICM SM Pvt Ltd
Alembic Pharmaceuticals Ltd
Alkem Laboratories Ltd
Altruist Biotechnology Ltd
Altaris
Anupam Rasayan India Ltd
Arinna Lifesciences Pvt Ltd
Aurobindo Pharma Ltd
Bavarian Nordic AS
Biodexa Pharmaceuticals PLC
Bliss GVS Pharma Ltd
Boehringer Ingelheim Pharmaceuticals
BrightGene Bio-Medical Technology Co Ltd
Bristol Myers Squibb
BYD
Carbogen Amcis AG
Charles River Laboratories
China Chamber of International Commerce
Cipla Ltd
Citeline/Informa
Crystal Pharmatech Co Ltd
dProtein Pharmaceutical Biotechnology Co Ltd
Earendil Labs Inc
Embio Ltd
Flowchem Pharma Pvt Ltd
Granules India Ltd
Hengrui
Henan Lvyuan Pharmaceutical Co Ltd
Indoco Remedies Ltd
Innovent
Intas Pharmaceuticals Ltd
Lupin Ltd
Mabwell Shanghai Bioscience Co Ltd
Morepen Laboratories Ltd
NAMSA
NSG BioLabs
Orchid Pharma Ltd
Pfizer
Porton Pharma Solutions Ltd / Proton Pharma Pvt Ltd
Quadria Capital Advisors Pvt Ltd
Rafa Laboratories Co Ltd
Recipharm Israel
Rubicon Research Ltd
Rusan Pharma Ltd
Sai Life Sciences Ltd
Samarth Life Sciences Pvt Ltd
Scinai Immunotherapeutics Ltd
Scinai Biopharma Services
Serum Institute of India Pvt Ltd
Shilpa Medicare Ltd
Sihuan Pharmaceutical Holdings Group Ltd
Solara Active Pharma Sciences Ltd
Solopharm
Supriya Lifescience Ltd
Summit Therapeutics
Sunways India Pvt Ltd
Syngene International Ltd
Torrent Pharmaceuticals Ltd
True North Capital
Wanbury Ltd
WuXi AppTec
WuXi ATU
WuXi Biologics
Zhejiang Jiuzhou Pharmaceutical Co Ltd
Zydus Lifesciences Ltd
Table of Contents
Table
Figures
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Contract Manufacturers reports